Retatrutide: Trillion-Dollar Claim
1:03:25–1:04:18 · 52s
Tatem predicts Lillys upcoming retatrutide could deliver 2025% weight loss and become a trillion-dollar drug, calling it the Ferrari of GLP-1s.
1:03:25–1:04:18 · 52s
Tatem predicts Lillys upcoming retatrutide could deliver 2025% weight loss and become a trillion-dollar drug, calling it the Ferrari of GLP-1s.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.